What does CUSIP 18978H201 represent in this 13F holders report?

CUSIP 18978H201 is the security identifier for CNSP - CNS PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held CNSP - CNS PHARMACEUTICALS INC - COM NEW in Q4 2022?

9 institutional investors reported CNSP - CNS PHARMACEUTICALS INC - COM NEW for Q4 2022. Use the holders table for investor-level position and value details.

CNS PHARMACEUTICALS INC - COM NEW (CNSP)

CUSIP: 18978H201

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / COM NEW
Total 13F shares: 139,376
Total 13F value: $334,999
Share change: +139,376
SEC-reported price per share: $2.40
Number of holders: 9
Value change: +$334,999
Number of buys: 9

Security key

18978H201

Report period

Q4 2022

Institutions

Top holders

CNSP full security history Ownership snapshot Full 13F holder table CNS Pharmaceuticals, Inc. SEC filings CNS Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CNSP - CNS PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Waldemar Priebe

Disclosed value leader

Waldemar Priebe

Comparable rows

0/15

Latest evidence

06 Dec 2022

3/4/5 13F Highest disclosed value: $198,486 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Waldemar Priebe has the largest disclosed position value at $198.5K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Waldemar Priebe's linked filing trail.

Disclosed position value Top 5

Waldemar Priebe $198.5K

VANGUARD GROUP INC $81K

Bank of New York Mellon Corp $36K

GEODE CAPITAL MANAGEMENT, LLC $23K

Virtu Financial LLC $23K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Waldemar Priebe	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$198,486 156,807 shares	—	06 Dec 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$81,000 453,615 shares	—	30 Sep 2022
Bank of New York Mellon Corp	13F Company 13F	— denominator unverified	$36,000 203,543 shares	—	30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$23,000 129,016 shares	—	30 Sep 2022
Virtu Financial LLC	13F Company 13F	— denominator unverified	$23,000 127,922 shares	—	30 Sep 2022
TWO SIGMA SECURITIES, LLC	13F Company 13F	— denominator unverified	$16,000 90,487 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

139,376

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %